Influence of acetazolamide loading on the (in vitro) performances of non-phospholipid-based cationic nanosized emulsion in comparison with phospholipid-based anionic and neutral-charged nanosized emulsions

Drug Development and Industrial Pharmacy

Volumn 37, Issue 9, 2011, Pages 1003-1015

  Tamilvanan, Shunmugaperumal ^a,b   Kumar, Balakrishnan Ajith ^b  

^a INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

^b ARULMIGU KALASALINGAM COLLEGE OF PHARMACY   (India)

Author keywords

Arachis oil; Cornea; Cryoprotectant; In vitro release; Permeation; Zeta potential

Indexed keywords

ACETAZOLAMIDE; CRYOPROTECTIVE AGENT; PHOSPHOLIPID;

ANIMAL TISSUE; ARTICLE; AUTOCLAVE; CRYOPROTECTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; FREEZE THAWING; IN VITRO STUDY; MATHEMATICAL MODEL; NANOEMULSION; NONHUMAN; PARTICLE SIZE; PH; VISCOSITY; ZETA POTENTIAL;

ACETAZOLAMIDE; ANIMALS; ANIONS; CARBONIC ANHYDRASE INHIBITORS; CATIONS; CORNEA; EMULSIONS; GOATS; HUMANS; MODELS, THEORETICAL; NANOPARTICLES; PERMEABILITY; PHOSPHOLIPIDS; SURFACE PROPERTIES;

EID: 79961158933     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2011.555407     Document Type: Article

References (44)

1. Kaur I P, Smitha R, Aggarwal D, Kapil M. (2002). Acetazolamide: future perspective in topical glaucoma therapeutics. Int J Pharm, 248:1-14. (Pubitemid 35341405)
2. Maus TL, Larsson LI, McLaren JW, Brubaker RF. (1997). Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor fow in humans. Arch Ophthalmol, 115:45-49. (Pubitemid 27034930)
3. Dufel MW, Ing IS, Segarra TM, Dixson JA, Barfknecht CF, Schoenwald RD. (1986). N-Substituted sulfonamide carbonic anhydrase inhibitors with topical efects on intraocular pressure. J Med Chem, 29:1488-1494. (Pubitemid 16034643)
4. Friedman Z, Allen RC, Raph SM. (1985). Topical acetazolamide and methazolamide delivered by contact lenses. Arch Ophthalmol, 103:963-966. (Pubitemid 16171947)
5. Tous SS, Nasser KAE. (1992). Acetazolamide topical formulation and ocular efect. STP Pharm Sci, 2:125-131.
6. Loftsson T, Frithriksdóttir H, Stefánsson E, Tórisdóttir S, Guthmundsson O, Sigthórsson T. (1994). Topically efective ocular hypotensive acetazolamide and ethoxyzolamide formulations in rabbits. J Pharm Pharmacol, 46:503-504. (Pubitemid 24179546)
7. Kaur IP, Smitha R. (2002). Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery. Drug Dev Ind Pharm, 28:473-493.
8. Kaur IP, Singh M, Kanwar M. (2000). Formulation and evaluation of ophthalmic preparations of acetazolamide. Int J Pharm, 199:119-127. (Pubitemid 30236183)
9. Kaur IP, Garg A, Singla AK, Aggarwal D. (2004). Vesicular systems in ocular drug delivery: an overview. Int J Pharm, 269:1-14. (Pubitemid 38035207)
10. Guinedi AS, Mortada ND, Mansour S, Hathout RM. (2005). Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm, 306:71-82. (Pubitemid 41643141)
11. El-Gazayerly ON, Hikal AH. (1997). Preparation and evaluation of acetazolamide liposomes as an ocular delivery system. Int J Pharm, 158:121-127. (Pubitemid 28012898)
12. Hathout RM, Mansour S, Mortada ND, Guinedi AS. (2007). Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS Pharmscitech, 8:1.
13. Tamilvanan S. (2008). Oil-in-water nanosized emulsions: medical applications. In: Gad SC, ed. Pharmaceutical Manufacturing Handbook. Hoboken, NJ: John Wiley & Sons Publishers, Chapter 7.4, pp. 1329-1368.
14. Tamilvanan S, Benita S. (2004). Te potential of lipid emulsion for ocular delivery of lipophilic drugs. Eur J Pharm Biopharm, 58:357-368. (Pubitemid 39037241)
15. Sahoo SK, Dilnawaz F, Krishnakumar S. (2008). Nanotechnology in ocular drug delivery. Drug Discov Today, 13:144-151.
16. Novagali Pharma completed a new Phase II with Cyclokat® in dry eye, Novagali Pharma Press Release-2009, accessed on January 20, 2010 at, http://www.novagali.com
17. Rojanasakul Y, Robinson JR. (1989). Transport mechanisms of the cornea: characterization of barrier permselectivity. Int J Pharm, 55:237-246. (Pubitemid 19253796)
18. Rabinovich-Guilatt L, Couvreur P, Lambert G, Goldstein D, Benita S, Dubernet C. (2004). Extensive surface studies help to analyse zeta potential data: the case of cationic emulsions. Chem Phys Lipids, 131:1-13. (Pubitemid 38802857)
19. Tamilvanan S, Khoury K, Gilhar D, Benita S. (2001). Ocular delivery of cyclosporin A. I. Design and characterization of cyclosporin A-loaded positively-charged submicron emulsion. STP Pharm Sci, 11:421-426. (Pubitemid 34016287)
20. Christensen D, Kirby D, Foged C, Agger EM, Andersen P, Perrie Y et al. (2008). Alpha,alpha′-trehalose 6,6′-dibehenate in non-phospholipid-based liposomes enables direct interaction with trehalose, ofering stability during freeze-drying. Biochim Biophys Acta, 1778:1365-1373.
21. Tamilvanan S, Kumar BA, Senthilkumar SR, Baskar R, Sekharan TR. (2010). Stability assessment of injectable castor oil-based nano-sized emulsion containing cationic droplets stabilized by poloxamer-chitosan emulsifer flms. AAPS Pharmscitech, 11:904-909.
22. Ajith Kumar B, Pandian S, Saravanan R, Tamilvanan S. (2008). Development of acetazolamide-loaded nanosized emulsions (o/w-type) for topical application into eye to reduce intraocular pressure in glaucomatous condition. Indian Association of Pharmaceutical Scientists & Technologists (IAPST) Conference, held at College of Pharmacy, Madras Medical College, Chennai, India, on November 23, 2008, Abstract no. 278.
23. Parasrampuria J, Das Gupta V. (1990). Development of oral liquid dosage forms of acetazolamide. J Pharm Sci, 79:835-836. (Pubitemid 20308998)
24. Wang LX, He HB, Tang X, Shao RY, Chen DW. (2006). A less irritant norcantharidin lipid microspheres: formulation and drug distribution. Int J Pharm, 323:161-167.
25. Férézou J, Nguyen TL, Leray C, Hajri T, Frey A, Cabaret Y et al. (1994). Lipid composition and structure of commercial parenteral emulsions. Biochim Biophys Acta, 1213:149-158. (Pubitemid 24222805)
26. Groves MJ, Wineberg M, Brain APR. (1985). Te presence of liposomal material in phosphatide stabilized emulsions. J Disper Sci Technol, 2:237-247.
27. Zhang HY, Tang X, Li HY, Liu XL. (2007). A lipid microsphere vehicle for vinorelbine: stability, safety and pharmacokinetics. Int J Pharm, 348:70-79. (Pubitemid 350266241)
28. Palma SD, Tartara LI, Quinteros D, Allemandi DA, Longhi MR, Granero GE. (2009). An efcient ternary complex of acetazolamide with HP-ss-CD and TEA for topical ocular administration. J Control Release, 138:24-31.
29. Moses RA. (1981). ADLER'S Physiology of the Eye Clinical Application. St. Louis, MO: The C.V. Mosby Company, pp. 16-23.
30. Camber O. (1985). An in vitro model for determination of drug permeability through the cornea. Acta Pharm Suec, 22:335-342. (Pubitemid 16184699)
31. Schoenwald RD, Huang HS. (1983). Corneal penetration behavior of beta-blocking agents I: physiochemical factors. J Pharm Sci, 72:1266-1272. (Pubitemid 14229733)
32. He CX, He ZG, Gao JQ. (2010). Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs. Expert Opin Drug Deliv, 7:445-460.
33. Grigoriev DO, Miller R. (2009). Mono-and multilayer covered drops as carriers. Curr Opin Colloid Interface Sci, 14:48-59.
34. Saito H, Kawagishi A, Tanaka M, Tanimoto T, Okada S, Komatsu H et al. (1999). Coalescence of lipid emulsions in foating and freeze-thawing processes: examination of the coalescence transition state theory. J Colloid Interface Sci, 219:129-134. (Pubitemid 29500872)
35. Ausborn M, Schreier H, Brezesinski G, Fabian H, Meyer HW, Nuhn P. (1994). Te protective efect of free and membrane bound cryoprotectants during freezing and freeze-drying of liposomes. J Control Rel, 30:105-116. (Pubitemid 24215429)
36. Komatsu H, Okada S, Handa T. (1997). Suppressive efects of salts on droplet coalescence in a commercially available fat emulsion during freezing for storage. J Pharm Sci, 86:497-502. (Pubitemid 27154768)
37. Strauss G, Hauser H. (1986). Stabilization of lipid bilayer vesicles by sucrose during freezing. Proc Natl Acad Sci usa, 83:2422-2426. (Pubitemid 16026897)
38. Harada T, Yokomizo K. (2000). Demulsifcation of oil-in-water emulsion under freezing conditions: efect of crystal structure modifer. J Am Oil Chem Soc, 77:859-863.
39. Vanapalli SA, Palanuwech J, Coupland JN. (2002). Stability of emulsions to dispersed phase crystallization: efect of oil type, dispersed phase volume fraction, and cooling rate. Colloid Surf A, 204:227-237. (Pubitemid 34450961)
40. Hagigit T, Nassar T, Behar-Cohen F, Lambert G, Benita S. (2008). Te infuence of cationic lipid type on in-vitro release kinetic profles of antisense oligonucleotide from cationic nanoemulsions. Eur J Pharm Biopharm, 70:248-259.
41. Bhaskar R, Murphy RSR, Miglani BD, Viswanathan K. (1986). Novel method to evaluate difusion controlled release of drug from resinate. Int J Pharm, 28:59-66. (Pubitemid 16210128)
42. Barar J, Javadzadeh AR, Omidi Y. (2008). Ocular novel drug delivery: impacts of membranes and barriers. Expert Opin Drug Deliv, 5:567-581. (Pubitemid 351877434)
43. Calvo P, Alonso MJ, Vila-Jato JL, Robinson JR. (1996). Improved ocular bioavailability of indomethacin by novel ocular drug carriers. J Pharm Pharmacol, 48:1147-1152. (Pubitemid 126449485)
44. Abdulrazik M, Tamilvanan S, Khoury K, Benita S. (2001). Ocular delivery of cyclosporin A. Part 2. Efect of submicron emulsion's surface charge on ocular distribution of topical cyclosporin A. STP Pharm Sci, 11:427-432. (Pubitemid 34016288)